Agenus Inc., a U.S. based immuno-oncology firm, has announced that it has started dosing its first patient with AGEN1223, a novel bi-specific antibody developed to reduce regulatory T cells in the tumor microenvironment. The initial dosing ....

  The biopharmaceutical firm reported positive results from the PEOPLE Phase-3 study of Viaskin Peanut in the children suffering from the peanut allergy. Patients produced long-term and durable clinical benefits with an additional....

Fingerprint Cards AB (Fingerprints™) has seemingly dominated the biometrics industry with its unique and innovative products. However, in a move to utilize the vast untapped market of biometric access control, the company has recently....

The Environmental Protection Agency (EPA) is contemplating rigorous regulations to curb pollution—nitrogen oxide (NOx)— from heavy duty-trucks. Heavy-duty vehicles are believed to be the largest mobile source of nitrogen oxide w....

Elvie, a UK-based health & lifestyle brand, focused upon innovating smarter technology for women recently announced the launch of its Insights app feature for Elvie Pump, which is the quietest, lightest and smallest wearable breast pump....

B-SIMPLE2 trial was statistically considerable for numerous pre-specified sensitivity analyses. Similar assessments with B-SIMPLE1 showed reasonably supportive and consistence results of B-SIMPLE2. Novan, Inc., a clinical-stage biotech....

The CoinEx Chain Foundation has reportedly announced the launch of its Support Program, that is designed to lend support to institutions and individuals and to encourage community development. In each quarter, the Foundation would commit a....

Radiologists miss nearly 20% of breast cancer spotting in mammograms Google’s AI technology is developed with Alphabet Inc.’s DeepMind AI   As per a latest study, a novel AI technology developed by American multinatio....

Based on the verticals, the mobile virtualization market can be segmented into retail, entertainment & media, manufacturing & supply chain management, BFSI, IT & telecom, healthcare & life sciences, public sector & educa....

Principia Biopharma Inc. recently updated about the anticipated timings for the final result from the ongoing trial of PRN1008 data in patients suffering from pemphigus, along with CRR (complete response rates) from its Phase II Part B tria....